Cripto-1 induces apoptosis in HC-11 mouse mammary epithelial cells

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Cripto-1 (CR-1) is an epidermal growth factor (EGF)-related protein with known roles in mammary epithelial cells.
• Previous studies indicate CR-1 can inhibit the expression of beta-casein and whey acidic protein.
• The precise role of CR-1 in regulating cell survival and death pathways remains to be fully elucidated.

Purpose of the Study:

• To investigate the effect of Cripto-1 (CR-1) on apoptosis induction in HC-11 mouse mammary epithelial cells.
• To identify the molecular mechanisms underlying CR-1-mediated apoptosis, including caspase activation and Bcl-xL regulation.
• To determine the temporal dynamics of CR-1-induced apoptosis in the absence of survival factors.

Main Methods:

• Induction of apoptosis in HC-11 cells using recombinant Cripto-1 (CR-1).
• Quantification of apoptosis via bis-benzimide staining, TUNEL assay, and cell death ELISA.
• Assessment of protein expression changes (PARP, beta-catenin, caspase-3, p27kip1, p21Bax, Bcl-xL) using Western blotting and caspase inhibitors.

Main Results:

• Cripto-1 (CR-1) treatment induced significant apoptosis in HC-11 cells after 2-3 days, particularly without EGF and insulin.
• CR-1 exposure led to decreased poly(ADP-ribose) polymerase (PARP) expression and increased beta-catenin cleavage, indicative of caspase activation.
• Caspase inhibition blocked CR-1-induced apoptosis; CR-1 upregulated caspase-3-like protease activity and decreased Bcl-xL levels, while p27kip1 and p21Bax remained unchanged.

Conclusions:

• Cripto-1 (CR-1) is a potent inducer of apoptosis in mouse mammary epithelial cells.
• The pro-apoptotic effect of CR-1 is mediated through the activation of caspase-3-like proteases.
• Downregulation of the anti-apoptotic protein Bcl-xL is a key event in CR-1-induced cell death.